Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Articles Tagged With:

  • Adolescents Know More About Abortion Restrictions than Most Expect

    Adolescents are fully aware and concerned about how abortion restrictions can affect them, and most use the internet and social media for information on abortion, new research shows.

  • Medication Abortion Through Telehealth Is Safe, Effective, and Convenient

    Researchers began studying the safety and effectiveness of telehealth medication abortions in 2021 and concluded in 2022 before the U.S. Supreme Court decision to overturn Roe v. Wade. The recently published results showed that telehealth medication abortions are safe, with outcomes of 99.8% without serious adverse events.

  • OB/GYNs Experiencing High Levels of Moral Distress

    An OB/GYN was asked by researchers how it felt to work in an abortion-ban state after the U.S. Supreme Court overturned Roe v. Wade — the physician’s response was shocking. The OB/GYN said working in a war zone with actual risk to one’s life was not as distressing as working with patients in an abortion-ban state where the physician continually feared arrest or patient death.

  • Telehealth Medication Abortion Remains Under Threat Even as Access Expands

    In June, the U.S. Supreme Court is expected to decide the fate of the abortion medication mifepristone — a decision that could undermine access to the medication at a time when major pharmacies and retailers have begun to offer the pill. Abortion rights advocates, reproductive health clinicians, and others are bracing for a decision that could upend access to safe, legal self-managed abortions for most or all women in the nation.

  • Opill Rollout Includes Major Pharmacies and Retailers — but Price Tag Needs Work

    The rollout of the nation’s first over-the-counter birth control pill, Opill, is a major step toward improving contraception access across the United States. But some obstacles remain, including cost and access for minors in places hostile to reproductive autonomy.

  • ‘I Need My Brain!’: Horrors of Long COVID in HCWs

    A systematic review of studies on healthcare workers who experienced long COVID in the United Kingdom revealed that many struggled to separate their clinical identity from that of a patient. Healthcare workers with various symptoms of long COVID endured over different lengths of time recognized the uncertainty of their symptoms of this poorly understood syndrome and feared they would be perceived as a burden.

  • An Old Pro Stays in the Fight Against Needlesticks

    At age 78, with more than 50 years of clinical consultation and research on needlesticks, sharps injuries, and medical waste, Terry Grimmond, FASM, BAgrSc, GrDpAdEdTr, says he retired at the end of 2023 but is still winding his career down with a few final projects.

  • Is Measles Elimination Status at Risk? Antivaxers Attack MMR Vaccine

    As the number of measles cases in the United States already has outstripped total cases for last year, employee health professionals should prepare for incoming cases that can wreak havoc in a hospital if undetected. Even if staff are fully immunized, all bets are off if an undiagnosed case of measles gets into a healthcare facility.

  • Healthcare Workers, CDC at Odds Over COVID Precautions

    Inundated with criticism from healthcare workers, highly vulnerable patients, and those with long COVID, advisors to the CDC must make a Solomonic decision. At a time when the CDC is trying to simplify and normalize community precautions for SARS-CoV-2, initial efforts to do so in the hospital have backfired spectacularly.

  • Novel Psychoactive Substances of Abuse: Part II

    This is the second of a two-part series. Part I reviewed stimulants and started the discussion of hallucinogens and psychedelics. Part II will finish the discussion of hallucinogens and conclude with novel sedative drugs.